Global Chinese Medicine Formula Granules Market Growth 2022-2028

The global market for Chinese Medicine Formula Granules is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Chinese Medicine Formula Granules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Chinese Medicine Formula Granules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Chinese Medicine Formula Granules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Chinese Medicine Formula Granules market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Chinese Medicine Formula Granules players cover Shandong Yifang Pharmaceutical Co., Ltd., Hubei Chenmei Traditional Chinese Medicine Co., Ltd., Jiangsu Kangyuan Pharmaceutical Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd. and Zhejiang Jingyuetang Pharmaceutical Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Chinese Medicine Formula Granules market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Chinese Medicine Formula Granules market, with both quantitative and qualitative data, to help readers understand how the Chinese Medicine Formula Granules market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Chinese Medicine Formula Granules market and forecasts the market size by Type (Cold Medication, Pain Medication and Others), by Application (Medical Institutions and Retail Pharmacy.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
    Cold Medication
    Pain Medication
    Others
Segmentation by application
    Medical Institutions
    Retail Pharmacy
Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries
Major companies covered
    Shandong Yifang Pharmaceutical Co., Ltd.
    Hubei Chenmei Traditional Chinese Medicine Co., Ltd.
    Jiangsu Kangyuan Pharmaceutical Co., Ltd.
    Hunan Xinhui Pharmaceutical Co., Ltd.
    Zhejiang Jingyuetang Pharmaceutical Co., Ltd.
    Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd.
    Sichuan New Green Pharmaceutical Technology Development Co., Ltd.
    Shijiazhuang Yiling Pharmaceutical Co., Ltd.
    Henan Hongri Kangrentang Pharmaceutical Co., Ltd.
    Hubei Yizheng Pharmaceutical Co., Ltd.
    TiandihengﾗPharmaceutical Co., Ltd.
    Liaoning SPH Good Nursing Pharmaceutical ((Group) Co., Ltd.
    Shineway Pharmaceutical Group Co., Ltd.
    China Resources Sanjiu Modern Chinese Medicine Pharmaceutical Co., Ltd.
    Beijing Chunfeng-Fang Pharmaceutical Co., Ltd.
    Inner Mongolia Pukang Pharmaceutical Co., Ltd.
    Guangdong Yifang Pharmaceutical Co., Ltd.
    Anhui Jiuzhou Fangyuan Pharmaceutical Co., Ltd.
    Beijing Kangrentang Pharmaceutical Co., Ltd.
    Jiangyin Tianjiang Pharmaceutical Co., Ltd.
Chapter Introduction
Chapter 1: Scope of Chinese Medicine Formula Granules, Research Methodology, etc.
Chapter 2: Executive Summary, global Chinese Medicine Formula Granules market size (sales and revenue) and CAGR, Chinese Medicine Formula Granules market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Chinese Medicine Formula Granules sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Chinese Medicine Formula Granules sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Chinese Medicine Formula Granules market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Shandong Yifang Pharmaceutical Co., Ltd., Hubei Chenmei Traditional Chinese Medicine Co., Ltd., Jiangsu Kangyuan Pharmaceutical Co., Ltd., Hunan Xinhui Pharmaceutical Co., Ltd., Zhejiang Jingyuetang Pharmaceutical Co., Ltd., Sinopharm Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sichuan New Green Pharmaceutical Technology Development Co., Ltd., Shijiazhuang Yiling Pharmaceutical Co., Ltd. and Henan Hongri Kangrentang Pharmaceutical Co., Ltd., etc.
Chapter 14: Research Findings and Conclusion